NO20030303D0 - Kalsilytiske forbindelser - Google Patents
Kalsilytiske forbindelserInfo
- Publication number
- NO20030303D0 NO20030303D0 NO20030303A NO20030303A NO20030303D0 NO 20030303 D0 NO20030303 D0 NO 20030303D0 NO 20030303 A NO20030303 A NO 20030303A NO 20030303 A NO20030303 A NO 20030303A NO 20030303 D0 NO20030303 D0 NO 20030303D0
- Authority
- NO
- Norway
- Prior art keywords
- calcilitic
- compounds
- calcilitic compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21984200P | 2000-07-21 | 2000-07-21 | |
| US22063600P | 2000-07-25 | 2000-07-25 | |
| PCT/US2001/022267 WO2002007673A2 (en) | 2000-07-21 | 2001-07-16 | Calcilytic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20030303D0 true NO20030303D0 (no) | 2003-01-20 |
| NO20030303L NO20030303L (no) | 2003-03-20 |
| NO325333B1 NO325333B1 (no) | 2008-03-31 |
Family
ID=26914307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030303A NO325333B1 (no) | 2000-07-21 | 2003-01-20 | Kalsilytiske forbindelser og anvendelsen av slike for fremstilling av et preparat for behandling av ulike lidelser |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1368318B1 (no) |
| JP (1) | JP2004509077A (no) |
| KR (1) | KR20030017642A (no) |
| CN (1) | CN1582275A (no) |
| AR (1) | AR033987A1 (no) |
| AT (1) | ATE380177T1 (no) |
| AU (2) | AU2001276923B2 (no) |
| BR (1) | BR0112600A (no) |
| CA (1) | CA2416537A1 (no) |
| CZ (1) | CZ2003142A3 (no) |
| DE (1) | DE60131781T2 (no) |
| ES (1) | ES2296774T3 (no) |
| HU (1) | HUP0300758A2 (no) |
| IL (1) | IL154058A0 (no) |
| MX (1) | MXPA03000556A (no) |
| MY (1) | MY133881A (no) |
| NO (1) | NO325333B1 (no) |
| PL (1) | PL365703A1 (no) |
| WO (1) | WO2002007673A2 (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001277752A1 (en) | 2000-08-11 | 2002-02-25 | Japan Tobacco Inc. | Calcium receptor antagonists |
| TWI316511B (en) | 2002-11-26 | 2009-11-01 | Smithkline Beecham Corp | Calcilytic compounds |
| SI1619180T1 (sl) | 2003-04-23 | 2010-04-30 | Japan Tobacco Inc | Antagonist CaSR |
| EP1630157A4 (en) | 2003-05-28 | 2007-05-23 | Japan Tobacco Inc | ANTAGONIST OF CASR |
| EP1809611A4 (en) * | 2004-10-06 | 2009-11-25 | Nps Pharma Inc | PYRIMIDINONE COMPOUNDS USED AS CALCILYTICS |
| EP2128136A4 (en) * | 2006-12-12 | 2012-01-04 | Nippon Zoki Pharmaceutical Co | DERIVATIVE OF 2-PHENYLNICOTINIC ACID |
| WO2009148052A1 (ja) | 2008-06-05 | 2009-12-10 | 旭化成ファーマ株式会社 | スルホンアミド化合物及びその用途 |
| WO2015089842A1 (en) * | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Novel tricyclic calcium sensing receptor antagonists for the treatment of osteoporosis |
| UY36548A (es) | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas |
| WO2024160842A1 (en) | 2023-01-30 | 2024-08-08 | Medizinische Universität Wien | Use of calcilytics for preventing or treating hypoparathyroidism associated with anterior neck surgery |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258379A (en) * | 1990-05-04 | 1993-11-02 | Eli Lilly And Company | Method of inhibiting gastric acid secretion with n-arylpiperazines |
| US5158956A (en) * | 1990-05-04 | 1992-10-27 | Eli Lilly And Company | Method of inhibiting gastric acid secretion with benzodioxanes |
| ATE298739T1 (de) * | 1996-04-09 | 2005-07-15 | Nps Pharma Inc | Calcylitische verbindungen |
| AR014975A1 (es) * | 1998-04-08 | 2001-04-11 | Nps Pharma Inc | Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento |
-
2001
- 2001-07-16 HU HU0300758A patent/HUP0300758A2/hu unknown
- 2001-07-16 EP EP01954696A patent/EP1368318B1/en not_active Expired - Lifetime
- 2001-07-16 DE DE60131781T patent/DE60131781T2/de not_active Expired - Fee Related
- 2001-07-16 AU AU2001276923A patent/AU2001276923B2/en not_active Expired - Fee Related
- 2001-07-16 PL PL01365703A patent/PL365703A1/xx not_active Application Discontinuation
- 2001-07-16 CN CNA018131166A patent/CN1582275A/zh active Pending
- 2001-07-16 KR KR10-2003-7000846A patent/KR20030017642A/ko not_active Ceased
- 2001-07-16 WO PCT/US2001/022267 patent/WO2002007673A2/en not_active Ceased
- 2001-07-16 CZ CZ2003142A patent/CZ2003142A3/cs unknown
- 2001-07-16 BR BR0112600-8A patent/BR0112600A/pt not_active Application Discontinuation
- 2001-07-16 IL IL15405801A patent/IL154058A0/xx unknown
- 2001-07-16 CA CA002416537A patent/CA2416537A1/en not_active Abandoned
- 2001-07-16 MX MXPA03000556A patent/MXPA03000556A/es active IP Right Grant
- 2001-07-16 ES ES01954696T patent/ES2296774T3/es not_active Expired - Lifetime
- 2001-07-16 AU AU7692301A patent/AU7692301A/xx active Pending
- 2001-07-16 JP JP2002513411A patent/JP2004509077A/ja not_active Withdrawn
- 2001-07-16 AT AT01954696T patent/ATE380177T1/de not_active IP Right Cessation
- 2001-07-19 MY MYPI20013427 patent/MY133881A/en unknown
- 2001-07-20 AR ARP010103456A patent/AR033987A1/es not_active Application Discontinuation
-
2003
- 2003-01-20 NO NO20030303A patent/NO325333B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1368318A2 (en) | 2003-12-10 |
| HUP0300758A2 (hu) | 2003-08-28 |
| ES2296774T3 (es) | 2008-05-01 |
| AR033987A1 (es) | 2004-01-21 |
| WO2002007673A2 (en) | 2002-01-31 |
| NO325333B1 (no) | 2008-03-31 |
| EP1368318B1 (en) | 2007-12-05 |
| MXPA03000556A (es) | 2003-06-06 |
| ATE380177T1 (de) | 2007-12-15 |
| CA2416537A1 (en) | 2002-01-31 |
| EP1368318A4 (en) | 2006-08-23 |
| DE60131781T2 (de) | 2008-12-24 |
| CZ2003142A3 (cs) | 2003-06-18 |
| MY133881A (en) | 2007-11-30 |
| JP2004509077A (ja) | 2004-03-25 |
| AU7692301A (en) | 2002-02-05 |
| DE60131781D1 (de) | 2008-01-17 |
| WO2002007673A3 (en) | 2003-10-16 |
| BR0112600A (pt) | 2003-06-24 |
| CN1582275A (zh) | 2005-02-16 |
| KR20030017642A (ko) | 2003-03-03 |
| AU2001276923B2 (en) | 2005-02-03 |
| IL154058A0 (en) | 2003-07-31 |
| PL365703A1 (en) | 2005-01-10 |
| NO20030303L (no) | 2003-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20026196L (no) | Kinazolinditosylatsalt-forbindelser | |
| DK1619192T3 (da) | Arylkondeserede azapolycykliske forbindelser | |
| NO20032585D0 (no) | ABCA-1 forhöyende forbindelser | |
| DK1226127T3 (da) | Substituerede phenylsulfamoylcarboxamider | |
| ATE307121T1 (de) | Substituierte arylpyrazine | |
| AR028393A1 (es) | Iminoazidas substituidas | |
| AR027983A1 (es) | Novedosos compuestos | |
| ID29755A (id) | Senyawa-senyawa organosilikon | |
| DE50112662D1 (de) | Substituierte benzoylcyclohexenone | |
| AR028302A1 (es) | Feniluracilos substituidos | |
| PT1299356E (pt) | Novos compostos | |
| ATE372338T1 (de) | Deshalogenverbindungen | |
| AR028220A1 (es) | Novedosos compuestos | |
| NO20030303L (no) | Kalsilytiske forbindelser | |
| NO20023508D0 (no) | Kalsilyttiske forbindelser | |
| NO20031837D0 (no) | Kalsilytiske forbindelser | |
| TR200100070A3 (tr) | Bilesim | |
| AR028399A1 (es) | Nuevos compuestos | |
| SE0003477D0 (sv) | Compounds | |
| SE0000263D0 (sv) | New compounds | |
| IS8574A (is) | Ný efnasambönd | |
| FI20050832L (fi) | Uudet yhdisteet | |
| SE0003640D0 (sv) | New compounds | |
| AR027949A1 (es) | Novedosos compuestos | |
| SE0002788D0 (sv) | New compounds |